Victory Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 310,414 shares of VRTX stock, worth $144 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
310,414
Previous 325,748 4.71%
Holding current value
$144 Million
Previous $153 Million 5.45%
% of portfolio
0.15%
Previous 0.16%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$460.0 - $505.78 $7.05 Million - $7.76 Million
-15,334 Reduced 4.71%
310,414 $144 Million
Q2 2024

Aug 05, 2024
SELL
$392.81 - $485.53 $32.2 Million - $39.8 Million
-81,906 Reduced 20.09%
325,748 $153 Million
Q1 2024

May 03, 2024
SELL
$407.69 - $446.08 $11.5 Million - $12.6 Million
-28,184 Reduced 6.47%
407,654 $170 Million
Q4 2023

Feb 05, 2024
SELL
$343.0 - $410.68 $48.9 Million - $58.6 Million
-142,613 Reduced 24.65%
435,838 $177 Million
Q3 2023

Nov 06, 2023
BUY
$338.18 - $362.46 $27.6 Million - $29.6 Million
81,615 Added 16.43%
578,451 $201 Million
Q2 2023

Jul 27, 2023
SELL
$314.42 - $351.91 $15.6 Million - $17.5 Million
-49,703 Reduced 9.09%
496,836 $175 Million
Q1 2023

May 02, 2023
BUY
$283.23 - $323.1 $14.5 Million - $16.5 Million
51,149 Added 10.32%
546,539 $172 Million
Q4 2022

Feb 10, 2023
BUY
$285.76 - $321.48 $1.2 Million - $1.34 Million
4,182 Added 0.85%
495,390 $143 Million
Q4 2022

Feb 09, 2023
SELL
$285.76 - $321.48 $9.23 Million - $10.4 Million
-32,316 Reduced 6.17%
491,208 $142 Million
Q3 2022

Nov 02, 2022
SELL
$273.83 - $305.53 $7.08 Million - $7.9 Million
-25,868 Reduced 4.71%
523,524 $152 Million
Q2 2022

Aug 01, 2022
BUY
$234.96 - $292.55 $6.54 Million - $8.15 Million
27,854 Added 5.34%
549,392 $155 Million
Q1 2022

May 04, 2022
BUY
$221.42 - $260.97 $77.7 Million - $91.6 Million
351,044 Added 205.9%
521,538 $138 Million
Q4 2021

Feb 07, 2022
BUY
$177.01 - $223.45 $834,956 - $1.05 Million
4,717 Added 2.85%
170,494 $37.4 Million
Q3 2021

Nov 02, 2021
BUY
$181.39 - $202.99 $1.15 Million - $1.28 Million
6,324 Added 3.97%
165,777 $30.1 Million
Q2 2021

Aug 03, 2021
SELL
$187.49 - $221.1 $77.6 Million - $91.5 Million
-413,825 Reduced 72.19%
159,453 $32.2 Million
Q1 2021

May 04, 2021
SELL
$207.02 - $241.31 $17.4 Million - $20.3 Million
-83,922 Reduced 12.77%
573,278 $123 Million
Q4 2020

Feb 01, 2021
BUY
$207.01 - $276.09 $21.6 Million - $28.8 Million
104,471 Added 18.9%
657,200 $155 Million
Q3 2020

Nov 09, 2020
SELL
$255.65 - $303.1 $8.22 Million - $9.74 Million
-32,147 Reduced 5.5%
552,729 $150 Million
Q2 2020

Aug 07, 2020
BUY
$225.48 - $295.8 $13.6 Million - $17.8 Million
60,251 Added 11.48%
584,876 $170 Million
Q1 2020

May 04, 2020
BUY
$199.77 - $247.81 $35.4 Million - $43.9 Million
176,974 Added 50.91%
524,625 $125 Million
Q4 2019

Feb 06, 2020
SELL
$166.71 - $223.91 $31.1 Million - $41.7 Million
-186,311 Reduced 34.89%
347,651 $76.1 Million
Q4 2019

Feb 04, 2020
BUY
$166.71 - $223.91 $64.3 Million - $86.4 Million
385,706 Added 260.16%
533,962 $121 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $21.5 Million - $24.2 Million
129,162 Added 676.45%
148,256 $25.1 Million
Q2 2019

Aug 15, 2019
BUY
$164.61 - $190.37 $11,028 - $12,754
67 Added 0.35%
19,094 $3.5 Million
Q1 2019

May 03, 2019
BUY
$163.73 - $194.7 $2.5 Million - $2.97 Million
15,258 Added 404.83%
19,027 $3.5 Million
Q4 2018

Feb 05, 2019
SELL
$151.91 - $192.21 $3,797 - $4,805
-25 Reduced 0.66%
3,769 $625,000
Q3 2018

Nov 01, 2018
SELL
$167.73 - $192.74 $7,715 - $8,866
-46 Reduced 1.2%
3,794 $731,000
Q2 2018

Aug 02, 2018
SELL
$145.72 - $169.96 $11,657 - $13,596
-80 Reduced 2.04%
3,840 $653,000
Q1 2018

May 04, 2018
SELL
$151.6 - $177.13 $11,370 - $13,284
-75 Reduced 1.88%
3,920 $639,000
Q4 2017

Feb 01, 2018
SELL
$137.28 - $155.55 $22,788 - $25,821
-166 Reduced 3.99%
3,995 $599,000
Q3 2017

Oct 27, 2017
SELL
$148.13 - $162.24 $19,256 - $21,091
-130 Reduced 3.03%
4,161 $633,000
Q2 2017

Aug 07, 2017
BUY
N/A
4,291
4,291 $553,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email